BVS-22081-09225 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-07-16
Dose 1 — Pfizer-BioNTech
2021-08-06
Dose 2 — Pfizer-BioNTech
2022-04-15
Registered in v-safe
2022-04-15
Dose 3 — Pfizer-BioNTech
2022-04-15
Health check-in — day 0, dose 3
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-04-16
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-04-17
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-04-19
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2022-04-20
Survey response — days 1–6 daily, dose 3
MedDRA: Back pain — Feeling: Good · Muscle or body aches

Free text: Pain in mid/upper back lung area, only right side

MedDRA releases: 2024-11 · check-in free text available
2022-04-21
Survey response — days 1–6 daily, dose 3
MedDRA: Back pain — Feeling: Fair · Muscle or body aches, Diarrhea

Free text: Same full but sharp pain in my mid/left side of my back

MedDRA releases: 2024-11 · check-in free text available
2022-04-22
Survey response — day 7, dose 3
MedDRA: Back pain — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Diarrhea

Free text: Back pain on the upper right side is still there

MedDRA releases: 2024-11 · check-in free text available
2022-05-01
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-05-06
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-05-13
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-05-20
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-05-27
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-07-15
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-10-14
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2023-04-17
Survey response — 12 months, dose 3
MedDRA: Anxiety, Depression — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

MedDRA releases: 2024-11
2023-04-17
Report sent to call center — 12 months, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2023-04-18
Call 1 — Could Not Reach Participant
2023-04-21
Call 2 — Could Not Reach Participant

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-07-16	Pfizer-BioNTech	No
2	2021-08-06	Pfizer-BioNTech	No
3	2022-04-15	Pfizer-BioNTech	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 11 — days 1–6 daily, dose 3

2022-04-20

Systemic reaction (other): Pain in mid/upper back lung area, only right side

2022-04-21

Systemic reaction (other): Same full but sharp pain in my mid/left side of my back

Release 11 — day 7, dose 3

2022-04-22

Systemic reaction (other): Back pain on the upper right side is still there

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anxiety	·	·	✓
SD	Depression	·	·	✓
SRO	Back pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release